IRB - Investment Analysis: Buy Signal or Bull Trap?
Back to ListInvestment Rating: 3.3
| Stock Code | IRB | Market Cap | 25,895 Cr. | Current Price | 21.4 ₹ | High / Low | 25.5 ₹ |
| Stock P/E | 25.8 | Book Value | 13.2 ₹ | Dividend Yield | 0.72 % | ROCE | 7.31 % |
| ROE | 6.55 % | Face Value | 1.00 ₹ | DMA 50 | 21.2 ₹ | DMA 200 | 21.7 ₹ |
| Chg in FII Hold | 0.52 % | Chg in DII Hold | 0.05 % | PAT Qtr | 390 Cr. | PAT Prev Qtr | 287 Cr. |
| RSI | 53.7 | MACD | -0.02 | Volume | 1,29,32,235 | Avg Vol 1Wk | 1,26,84,012 |
| Low price | 18.5 ₹ | High price | 25.5 ₹ | PEG Ratio | 0.66 | Debt to equity | 0.74 |
| 52w Index | 42.1 % | Qtr Profit Var | 40.0 % | EPS | 0.83 ₹ | Industry PE | 17.6 |
📊 IRB shows moderate potential for long-term investment. The P/E (25.8) is higher than the industry average (17.6), suggesting slight overvaluation. ROE (6.55%) and ROCE (7.31%) are modest, indicating average efficiency. However, PEG ratio (0.66) suggests undervaluation relative to growth. Debt-to-equity (0.74) is manageable, and dividend yield (0.72%) provides some income support. PAT growth (390 Cr. vs 287 Cr.) shows strong quarterly momentum. Current price (21.4 ₹) is near both 50 DMA (21.2 ₹) and 200 DMA (21.7 ₹), reflecting consolidation.
💡 Ideal Entry Zone: 19 ₹ – 21 ₹, closer to support levels (DMA 50 & 200), offering safer entry.
📈 Exit / Holding Strategy: If already holding, maintain for 2–3 years to capture growth, provided profitability improves. Exit near 25–26 ₹ resistance unless ROE and ROCE strengthen. Long-term investors should monitor earnings consistency and valuation relative to industry peers.
Positive ✅
- 📈 PEG ratio (0.66) indicates undervaluation relative to growth
- 📊 Manageable debt-to-equity (0.74)
- 📈 Strong quarterly PAT growth (40%)
- 📊 Increase in FII (+0.52%) and DII (+0.05%) holdings
Limitation ⚠️
- 📉 P/E (25.8) higher than industry average (17.6)
- 📊 Modest ROE (6.55%) and ROCE (7.31%)
- 📉 EPS at 0.83 ₹ is relatively low
Company Negative News 📰
- ⚠️ Profitability metrics remain modest despite revenue growth
- 📉 Valuation slightly stretched compared to industry peers
Company Positive News 🌟
- 📈 PAT growth from 287 Cr. to 390 Cr. (40% increase)
- 📊 Institutional confidence with FII and DII holding increases
Industry 🌐
- 📊 Industry P/E at 17.6 vs IRB’s 25.8, showing slight overvaluation
- 🏗️ Infrastructure and road development sector benefits from government spending and economic expansion
Conclusion 📌
⚖️ IRB offers moderate investment potential with undervaluation on growth metrics (PEG) and strong quarterly earnings momentum. However, modest ROE/ROCE and slightly stretched P/E limit attractiveness. Best suited for medium-term investors (2–3 years) targeting 25–26 ₹ exit, while monitoring profitability improvements and sector growth trends.